secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001493152-26-021767
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.95
Item codes: 1.01, 2.01, 3.02, 3.03, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharma completes merger with United Dogecoin, pivots to crypto, raises $9.55M PIPE
--------------------------------------------------------------------------------

- Merger with United Dogecoin closed May 6; Shuttle issued 8,403 Series B-1 Preferred shares convertible at $1.24.
- Closed $9.55M PIPE financing with Series B-2 Preferred and Common Warrants, convertible at $1.03.
- Appointed Ryan Trasolini (ex-United Dogecoin CEO) as Co-Chief Executive Officer effective at closing.
- Amended Asset Purchase Agreement: paid $3.65M cash, issued 270 Series B-1 shares; seller returned 320,496 common shares.
- Director Oleh Nabyt resigned May 3 with no disagreement with management or board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315226021767/0001493152-26-021767-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315226021767/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-021767

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer